EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Digitalizing the design-make-test-analyze workflow in drug discovery with an electronic inventory platform

Ting Qin, Aparna Chandrasekaran, Jason Shiers, Matthew Crittall, Ciaran O'Reilly, Colin Sambrook Smith

SLAS Technology · 2025-06 · 32 · 100262

DOI: 10.1016/j.slast.2025.100262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SLAS Technology, 2025-06. Verfasst von Ting Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sygnature Discovery Ltd., BioCity, Pennyfoot Street, Nottingham, United Kingdom. Electronic address: t.qin@sygnaturediscovery.com. Hauptthemen laut MEDLINE: Drug Discovery, Workflow. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug discovery is a collaborative endeavor that often involves scientists from various disciplines and global collaborators. Efficient real-time sharing and updating of design-make-test-analyze (DMTA) information remains a challenge in drug discovery, hindering timely decision-making and project advancement. We propose a novel approach utilizing existing electronic inventory systems as DMTA workflow tracking platforms. Our approach at Sygnature Discovery leverages the inherent flexibility of these systems, allowing us to tailor stages and compound information to individual project needs, resulting in significant cost savings compared with building an in-house solution or purchasing a commercial solution. Given the wide adoption of electronic inventory platforms in drug discovery, our strategy holds immense potential for easy adoption and broad application across the industry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryWorkflow

Stichwörter der Autor:innen

Design-make-test-analysis workflowDrug discoveryElectronic inventory platform

Autor:innen und Institutionen

  • Sygnature Discovery Ltd., BioCity, Pennyfoot Street, Nottingham, United Kingdom. Electronic address: t.qin@sygnaturediscovery.com.
  • Sygnature Discovery Ltd., BioCity, Pennyfoot Street, Nottingham, United Kingdom.

Zitieren

APA

Qin, T., Chandrasekaran, A., Shiers, J., Crittall, M., O'Reilly, C., & Smith, C. S. (2025). Digitalizing the design-make-test-analyze workflow in drug discovery with an electronic inventory platform. SLAS Technology, 32, 100262. https://doi.org/10.1016/j.slast.2025.100262

Vancouver

Qin T, Chandrasekaran A, Shiers J, Crittall M, O'Reilly C, Smith CS. Digitalizing the design-make-test-analyze workflow in drug discovery with an electronic inventory platform. SLAS Technology. 2025;32:100262. doi:10.1016/j.slast.2025.100262

BibTeX
@article{Qin2025,
  author = {Qin, Ting and Chandrasekaran, Aparna and Shiers, Jason and Crittall, Matthew and O'Reilly, Ciaran and Smith, Colin Sambrook},
  title = {Digitalizing the design-make-test-analyze workflow in drug discovery with an electronic inventory platform},
  journal = {SLAS Technology},
  year = {2025},
  volume = {32},
  pages = {100262},
  doi = {10.1016/j.slast.2025.100262}
}
Kostenlos starten →